MarketCap
Facebook
X
TelegramQuartalsbericht 2024-Q2
hinzugefügt 07.08.2024
Alimera Sciences EV 2011-2026 | ALIM
EV Jährlich Alimera Sciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 197 M | 70.4 M | 13.3 M | 83.8 M | 77.8 M | 42.3 M | 26.2 M | 17.8 M | 19.9 M | -2.18 M | 25.6 M | -32.3 M | -20.7 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 197 M | -32.3 M | 39.9 M |
EV anderer Aktien in der Arzneimittelhersteller
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Aerie Pharmaceuticals
AERI
|
737 M | - | - | $ 754 M |  USA |
 |
AcelRx Pharmaceuticals
ACRX
|
23.6 M | - | 7.5 % | $ 6.35 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
28.5 M | - | 0.86 % | $ 117 M | USA |
 |
Agile Therapeutics
AGRX
|
25.3 M | - | 10.11 % | $ 58.2 M | USA |
 |
Canopy Growth Corporation
CGC
|
459 M | $ 1.1 | 2.84 % | $ 118 M |  Canada |
 |
Cronos Group
CRON
|
3.84 B | $ 2.64 | 1.35 % | $ 1.38 B | Canada |
 |
Catalent
CTLT
|
16.7 B | - | - | $ 11.5 B | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
756 M | - | - | $ 2.06 B |  France |
 |
China Pharma Holdings
CPHI
|
11.1 M | $ 0.59 | 6.08 % | $ 10.3 M |  China |
 |
DURECT Corporation
DRRX
|
3.37 M | - | - | $ 50.1 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
124 M | $ 3.81 | -16.81 % | $ 53.6 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
457 M | - | -39.89 % | $ 27.7 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
10.2 M | - | -0.1 % | $ 2.03 B |  Schweden |
 |
Endo International plc
ENDP
|
-710 M | - | - | $ 28.9 M |  Irlanda |
 |
Evolus
EOLS
|
467 M | $ 5.68 | 37.53 % | $ 366 M | USA |
 |
HEXO Corp.
HEXO
|
284 M | - | 2.45 % | $ 38.1 M | Canada |
 |
Evoke Pharma
EVOK
|
7.15 M | - | - | $ 36.6 M | USA |
 |
Harrow Health
HROW
|
2.21 B | $ 40.02 | 3.65 % | $ 1.47 B | USA |
 |
Aurora Cannabis
ACB
|
106 M | $ 3.65 | 4.89 % | $ 86.3 M | Canada |
 |
Athenex
ATNX
|
209 M | - | -23.39 % | $ 1.76 M | USA |
 |
Jupiter Wellness
JUPW
|
91.9 M | - | - | $ 33.6 M | USA |
 |
Emergent BioSolutions
EBS
|
1.2 B | $ 8.95 | 0.39 % | $ 458 M | USA |
 |
Assertio Holdings
ASRT
|
141 M | $ 12.19 | 2.48 % | $ 866 M | USA |
 |
Bausch Health Companies
BHC
|
29.9 B | $ 5.67 | -0.87 % | $ 2.07 B | Canada |
 |
Lannett Company
LCI
|
648 M | - | 1.15 % | $ 7.11 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
-110 M | - | - | $ 193 M | Canada |
 |
OrganiGram Holdings
OGI
|
456 M | $ 1.4 | 2.19 % | $ 402 M | Canada |
 |
Organogenesis Holdings
ORGO
|
392 M | $ 2.87 | 0.01 % | $ 378 M | USA |
 |
Sundial Growers
SNDL
|
-2.47 M | $ 1.55 | 1.21 % | $ 3.37 M | Canada |
 |
Perrigo Company plc
PRGO
|
7.03 B | $ 11.71 | 2.81 % | $ 1.62 B | USA |
 |
ProPhase Labs
PRPH
|
145 M | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
700 M | - | - | $ 1.42 B | USA |
 |
Rockwell Medical
RMTI
|
57.3 M | $ 0.91 | 1.03 % | $ 21.2 M | USA |
 |
Pacira BioSciences
PCRX
|
1.68 B | $ 22.92 | 3.69 % | $ 1.06 B | USA |
 |
PetIQ
PETQ
|
280 M | - | 1.64 % | $ 400 M | USA |
 |
OptiNose
OPTN
|
312 M | - | - | $ 1.08 B | USA |
 |
PLx Pharma
PLXP
|
73.8 M | - | -27.8 % | $ 2.56 M | USA |
 |
Recro Pharma
REPH
|
220 M | - | -4.76 % | $ 65.3 M | USA |
 |
Relmada Therapeutics
RLMD
|
170 M | $ 4.79 | 2.57 % | $ 144 M | USA |
 |
SCYNEXIS
SCYX
|
91.7 M | $ 0.76 | 1.22 % | $ 36.4 M | USA |
 |
Solid Biosciences
SLDB
|
197 M | $ 6.14 | 3.02 % | $ 251 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
7.57 M | $ 2.74 | -0.36 % | $ 3.4 M | USA |
 |
Tricida
TCDA
|
506 M | - | - | $ 3.25 M | USA |
 |
TherapeuticsMD
TXMD
|
33.6 M | $ 2.25 | 1.35 % | $ 23.5 M | USA |
 |
Tilray
TLRY
|
1.96 B | $ 7.33 | -0.48 % | $ 4.53 B | Canada |
 |
Veru
VERU
|
111 M | $ 2.53 | 0.4 % | $ 341 M | USA |
 |
Viatris
VTRS
|
41.3 B | $ 14.74 | -1.04 % | $ 17.7 B | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-22.6 M | - | - | $ 55.5 M | USA |
 |
cbdMD
YCBD
|
7.85 M | $ 0.75 | -2.76 % | $ 3.23 M | USA |